From Casetext: Smarter Legal Research

Arizona Apple Orchards v. Guyana Pharmaceutical Corp.

United States Court of Appeals, Ninth Circuit
Nov 16, 2001
23 F. App'x 708 (9th Cir. 2001)

Summary

holding that central bank's failure to release foreign currency under foreign exchange regulations was a sovereign act

Summary of this case from Burnett v. Cent. Bank of Belize

Opinion


23 Fed.Appx. 708 (9th Cir. 2001) ARIZONA APPLE ORCHARDS, an Arizona Corporation, Plaintiff--Appellee, v. GUYANA PHARMACEUTICAL CORPORATION, a corporation wholly owned by the sovereign nation of Guyana, Defendant, and Bank of Guyana, the Central Bank of Guyana, Defendant--Appellant. No. 00-15303. D.C. No. CV-98-01815-ROS. United States Court of Appeals, Ninth Circuit. November 16, 2001

Argued and Submitted November 7, 2001.

Argued by appellant only.

NOT FOR PUBLICATION. (See Federal Rule of Appellate Procedure Rule 36-3)

Exporter brought action against Guyanese bank, that functioned as central bank for Guyana, alleging that bank interfered with exporter's assignor's contract with Guyanese importer by refusing to release foreign currency required for importer to make payment through its own commercial bank to exporter. The United States District Court for the District of Arizona, Roslyn O. Silver, J., denied bank's motion to dismiss. Bank appealed. The Court of Appeals held that bank had immunity to lawsuit through Foreign Sovereign Immunities Act (FSIA).

Reversed.

Appeal from the United States District Court for the District of Arizona, Roslyn O. Silver, District Judge, Presiding.

Before FERNANDEZ, RYMER, and WARDLAW, Circuit Judges.

MEMORANDUM

This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by 9th Cir. R. 36-3.

The Bank of Guyana appeals from the district court's order denying its motion to dismiss Arizona Apple Orchards's suit based on the Foreign Sovereign Immunities Act, 28 U.S.C. §§ 1602-11 (FSIA). We have jurisdiction under the collateral order doctrine, see Adler v. Federal Republic of Nigeria, 107 F.3d 720, 723 (9th Cir.1997), and we reverse.

Arizona Apple complains that the Bank, which is the central bank of Guyana, interfered with its assignor's contract with Guyana Pharmaceutical Corporation by refusing to release the foreign currency required for Guyana Pharmaceutical to make payment through its own commercial bank to Arizona Apple. The Bank argues that it only administered Guyana's External Payment Deposit Scheme

Page 709.

(EPDS) and that the exchange rate guarantees were not commercial guarantees or contractual obligations to Arizona Apple's assignor. Arizona Apple counters that the Bank offered exchange rate guarantees in connection with a commercial activity.

Arizona Apple's position turns on its view that banks regularly exchange one currency for another at a specified rate, and that the Bank here effectively guaranteed the debts of Guyanese importers. See Republic of Argentina v. Weltover, Inc., 504 U.S. 607, 112 S.Ct. 2160, 119 L.Ed.2d 394 (1992). But this is not what the Bank did. The Bank offered Guyanese importers exchange rate guarantees that Guyana dollars deposited into their local commercial bank and in turn with the Bank of Guyana through EPDS would be converted into foreign currency at a pre-determined rate if and when sufficient foreign currency should become available. There is no evidence suggesting that banks ordinarily control the collection and distribution of foreign currency for all importers in a country; this seems clearly to be a central bank function. Neither the guarantees to Guyanese importers nor the Bank's alleged failure to honor them forms the basis of Arizona Apple's claims, which are based solely on the Bank's failure to release foreign currency to Guyana Pharmaceutical's commercial bank pursuant to Guyanese foreign exchange regulations. This is a sovereign activity that only a sovereign can do. See Weltover, 504 U.S. at 614; see also Corzo v. Banco Central de Reserva Del Peru, 243 F.3d 519, 525 (9th Cir.2001).

Thus, the Bank was not acting as a private player in the commercial market but rather was managing foreign exchange. Neither acknowledging receipt of Arizona Apple's assignment nor advising it of the possibility of a debt buy-back through counsel demonstrates otherwise. Accordingly, the Bank enjoys immunity from suit.

REVERSED.


Summaries of

Arizona Apple Orchards v. Guyana Pharmaceutical Corp.

United States Court of Appeals, Ninth Circuit
Nov 16, 2001
23 F. App'x 708 (9th Cir. 2001)

holding that central bank's failure to release foreign currency under foreign exchange regulations was a sovereign act

Summary of this case from Burnett v. Cent. Bank of Belize
Case details for

Arizona Apple Orchards v. Guyana Pharmaceutical Corp.

Case Details

Full title:ARIZONA APPLE ORCHARDS, an Arizona Corporation, Plaintiff--Appellee, v…

Court:United States Court of Appeals, Ninth Circuit

Date published: Nov 16, 2001

Citations

23 F. App'x 708 (9th Cir. 2001)

Citing Cases

Burnett v. Cent. Bank of Belize

See Fed. R. Evid. 902(3) ("The document must be accompanied by a final certification that certifies the…